Literature DB >> 6161157

Fc (IgG) receptors on rat basophilic leukemia cells.

D M Segal, S O Sharrow, J F Jones, R P Siraganian.   

Abstract

Receptors for IgG and IgE on rat basophilic leukemia cells (the 2H3 subline of RBL-IV) were detected by their ability bind IgE and IgG in fluorescence or radioactive assays. The 2H3 cells have approximately two-thirds as many receptors for IgG as for IgE. The IgE receptors bind monomeric IgE with high affinity and IgE binding is uninhibited by high concentrations of monomeric or oligomeric IgG. In contrast, the IgG receptors bind both (rabbit and rat) IgG and (rat) IgE. The affinity of IgG receptors for monomeric IgG and IgE is much lower than that of the IgE receptor for its ligand; binding of radiolabeled IgG or IgE to IgG receptors can be detected only with cross-linked oligomers. Although both receptors are sensitive to tryptic digestion than IgE receptors. Dual laser flow microfluorometric studies revealed that the numbers of IgG and IgE receptors per cell varied considerably among 2H3 cells and that the distributions of the 2 types of receptors were independent of each other. 2H3 cells released histamine through an IgE-mediated system, but cross-linked IgG, even in saturating amounts, did not elicit histamine release, nor have any effect upon IgE-induced release. Moreover, 2H3 cells would not mediate ADCC of IgG-coated chicken red blood cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161157

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Antibody cross-linking of human CD9 and the high-affinity immunoglobulin E receptor stimulates secretion from transfected rat basophilic leukaemia cells.

Authors:  A Higginbottom; I Wilkinson; B McCullough; F Lanza; D O Azorsa; L J Partridge; P N Monk
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

2.  Production of tumour necrosis factor by mastocytoma P815 cells.

Authors:  I Ohno; Y Tanno; K Yamauchi; T Takishima
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

3.  Identification of an IgE-binding protein by molecular cloning.

Authors:  F T Liu; K Albrandt; E Mendel; A Kulczycki; N K Orida
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  Qa alloantigen expression on functional T lymphocytes from spleen and thymus.

Authors:  R Rabinowitz; S O Sharrow; S Chatterjee-Das; M J Rogers; D H Sachs
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

5.  Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies.

Authors:  S O Sharrow; L Flaherty; D H Sachs
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

6.  Generation of monoclonal murine anti-DNP-IgE, IgM and IgG1 antibodies: biochemical and biological characterization.

Authors:  A Bohn; W König
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

7.  Monoclonal murine anti-DNP IgE: in vitro histamine release of rat mast cells in the presence of reaginic rat and mouse sera.

Authors:  A Bohn; W König
Journal:  Agents Actions       Date:  1985-09

8.  In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.

Authors:  M Sykes; M L Romick; K A Hoyles; D H Sachs
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

9.  Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide.

Authors:  P Ballerini; A Franchi; P Fuschiotti; D Piccioni; E Bonmassar
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

10.  Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE.

Authors:  E Wollmann; C Hamsten; E Sibanda; M Ochome; M Focke-Tejkl; A Asarnoj; A Önell; G Lilja; D Gallerano; C Lupinek; T Thalhamer; R Weiss; J Thalhamer; M Wickman; R Valenta; M van Hage
Journal:  Allergy       Date:  2015-03-22       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.